Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MacroGenics, Inc. - Common Stock (NQ:MGNX)

1.490 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
The Latest Analyst Ratings for Macrogenics
 
Via Benzinga
7 Analysts Have This to Say About Macrogenics
 
Via Benzinga
Expert Ratings for Macrogenics
 
Via Benzinga
What 7 Analyst Ratings Have To Say About Macrogenics
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
Where Macrogenics Stands With Analysts
 
Via Benzinga
Why Shares of MacroGenics Were Dropping Tuesday
Profit-taking and an analyst downgrade affected the stock's price. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients
 
Via Benzinga
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market... 
Via Benzinga
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
From MacroGenics, Inc.
Via GlobeNewswire
$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Friday, there were a few notable insider trades. 
Via Benzinga
Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56%
Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday. 
Via Benzinga
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to... 
Via Benzinga
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching. 
Via Investor's Business Daily
Dow Jumps Over 300 Points; S&P 500 Rises 1%
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday. 
Via Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... 
Via Benzinga
Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
US Stocks Open Higher As Dow Surges 250 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Tuesday. 
Via Benzinga
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles
 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS